RedHill Biopharma Advances Opaganib for GI-ARS Treatment

TipRanksDec 10 07:28 ET

RedHill Biopharma Announced Results From New In Vivo Studies Of Opaganib For Gastrointestinal Acute Radiation Syndrome, Undertaken As Part Of The U.S. Government's Radiation And Nuclear Countermeasures Program Contract That Further Confirms Opaganib's...

BenzingaDec 10 07:14 ET

Express News | Redhill Biopharma Has Been Awarded Approximately $8M Plus Costs In A Summary Judgment By The Supreme Court Of The State Of New York, New York County, In Its Legal Proceedings Against South Korea-based Kukbo

BenzingaDec 2 07:05 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to Its Board of Directors

PR NewswireNov 4 07:30 ET

RedHill Biopharma to Present Opaganib at U.S. Defense Conference

TipRanksOct 28 07:29 ET